We have also reported that a lower proportion of CD71+ erythroid cells was associated with worse pregnancy outcomes [15], suggesting that the maternal immune changes in IBD may significantly influence pregnancy-related outcomes in IBD. This evidence concerns the gene TFRC and inflammatory bowel disease.